Future Diagnostics BV

Click Here To EMAIL INQUIRY
Contact: R.F. Laport
Web: http://www.future-diagnostics.nl
E-Mail:
Address: Nieuweweg 172, 6603, Wychen 6603 BT, Netherlands
Phone: +31-(24)-64 52 900 | Fax: +31-(24)-64 52 899 | Map/Directions >>

Profile: Future Diagnostics BV is an immunoassay contract research and development company. We develop & market a line of assays and a lab on a cart platform targeted to niche markets such as the monitoring of endocrine surgery in real time, cell transplantation & brain damage assessment. We develop assays for various analytes including bone, infectious diseases, oncology, reproductive, endocrine, anemia, cardiovascular, drug, and autoimmune.

FDA Registration Number: 3012229005

2 Products/Services (Click for related suppliers)

• Ng1m(A) Antiserum Antigen Control (FDA Code: DGX / 866.5065)

A human allotypic marker immunological test system is a device that consists of the reagents used to identify by immunochemical techniques the inherited human protein allotypic markers (such as nGm, nA2m, and Km allotypes) in serum and other body fluids. The identification may be used while studying population genetics.

• Parathyroid Hormone Radioimmunoassay Test (FDA Code: CEW / 862.1545)

A parathyroid hormone test system is a device intended to measure the levels of parathyroid hormone in serum and plasma. Measurements of parathyroid hormone levels are used in the differential diagnosis of hypercalcemia (abnormally high levels of calcium in the blood) and hypocalcemia (abnormally low levels of calcium in the blood) resulting from disorders of calcium metabolism.